BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-2 out of 2 found
  Current Search:  melas: 2     
HTML
100%
Santhera Enters Agreement with Columbia University to Investigate Additional Potential of Catena in MELAS
- Santhera Pharmaceuticals announced a collaboration with Columbia University in New York to investigate Catena in a Phase II study as treatment of MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes).

The ...

Bionity.com:  Jun 29 2009 4:55AM
Matching: melas 		Find similar documents
HTML
100%
Santhera Pharmaceuticals signs research agreement with Columbia University
Santhera Pharmaceuticals AG, a Switzerland-based specialty pharmaceutical company, has signed an agreement with Columbia University to investigate Catena in a phase II study as treatment of MELAS (Mitochondrial Encephalopathy, Lactic...
Individual.com:  Jun 26 2009 7:59PM
Matching: melas 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.